Clinical Trials Browser

NIH × Breast Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Adenocarcinoma, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT00028496 2013-01-25

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

BreastGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Carcinoma, Medullary, Breast Neoplasms, Male

NCT00001338 2008-03-04

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Phase 3 Completed

65 enrolled

Breast

Breast Neoplasms, Fever, Hematologic Diseases, Neutropenia, Sepsis

Clinical Trials

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer